Furosemide and Nimodipine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Furosemide (furosemide) and Nimodipine (nimodipine). Common drug interactions include mixed liver injury among females and hypotension among males.

The phase IV clinical study analyzes what interactions people have when they take Furosemide and Nimodipine. It is created by eHealthMe based on reports of 44 people who take the same drugs from the FDA, and is updated regularly.

What is Furosemide?

Furosemide has active ingredients of furosemide. It is often used in fluid retention. eHealthMe is studying from 316,095 Furosemide users. Check the latest studies of Furosemide.

What is Nimodipine?

Nimodipine has active ingredients of nimodipine. eHealthMe is studying from 1,330 Nimodipine users. Check the latest studies of Nimodipine.

On Jul, 26, 2026

44 people who take Furosemide and Nimodipine together, and have interactions are studied.

Furosemide and Nimodipine drug interactions.

What are the common drug interactions of Furosemide and Nimodipine, by gender? *:

female:

Mixed liver injury
Abdominal pain
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Diarrhoea
Flatulence (flatus expelled through the anus)
Alanine aminotransferase increased
Blood creatinine increased
Confusional state
Device related infection
Febrile neutropenia (fever with reduced white blood cells)

male:

Hypotension (abnormally low blood pressure)
Syncope (loss of consciousness with an inability to maintain postural tone)
Somnolence (a state of near-sleep, a strong desire for sleep)
Blood pressure decreased
Bradycardia (abnormally slow heart action)
Cardiac arrest
Cardiac failure
Chronic obstructive airways disease
Digoxin toxicity
Dyspepsia (indigestion)

What are the common drug interactions of Furosemide and Nimodipine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Blood lactate dehydrogenase increased
Haemoglobin decreased
Haptoglobin decreased
Neutropenia (an abnormally low number of neutrophils)
Pain in extremity
Thrombocytopenia (decrease of platelets in blood)
Hyperglycaemia (high blood sugar)
Pancreatitis acute (sudden inflammation of pancreas)

20-29:

Subarachnoid haemorrhage (blood leaks into the space between two membranes that surround the brain)

30-39:

Cardiac arrest
Pyrexia (fever)

40-49:

Mixed liver injury

50-59:

Alanine aminotransferase increased
Blood creatinine increased
Device related infection
Febrile neutropenia (fever with reduced white blood cells)
Blood pressure decreased
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Electrolyte imbalance
Renal impairment (severely reduced kidney function)
Respiratory failure (inadequate gas exchange by the respiratory system)

60+:

Abdominal pain
Diarrhoea
Aphasia (damage to the parts of the brain that control language)
Blood pressure fluctuation
Bradycardia (abnormally slow heart action)
Cardiac failure
Cerebral haemorrhage (bleeding within the brain)
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Chronic obstructive airways disease
Confusional state

What are the existing conditions these people have? *

High Blood Pressure: 8 people, 18.18%
Respiratory Tract Infection: 6 people, 13.64%
Urine Output - Decreased: 5 people, 11.36%
Subclavian Vein Thrombosis (abnormal condition in which a clot develops within the subclavian or axillary vein): 5 people, 11.36%
Status Epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure): 5 people, 11.36%
Pneumonia: 5 people, 11.36%

* Approximation only. Some reports may have incomplete information.

Do you take Furosemide and Nimodipine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously